Articles with public access mandates - Kyrre E. EmblemLearn more
Not available anywhere: 5
Review
Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
A Latysheva, KE Emblem, P Brandal, EO Vik-Mo, J Pahnke, K Røysland, ...
Neuroradiology 61, 545-555, 2019
Mandates: German Research Foundation, Leibniz Association, European Commission …
Review
Dynamic Susceptibility Contrast MRI: Basic Physics, Pulse Sequences, and Modeling
E Grøvik, A Bjørnerud, KE Emblem
Advances in Magnetic Resonance Technology and Applications 1, 345-367, 2020
Mandates: European Commission, Research Council of Norway
Review
P11. 75. B PSEUDOPROGRESSION IN A REAL-WORLD GLIOBLASTOMA COHORT: INCIDENCE, MANAGEMENT, PROGNOSTIC IMPACT, AND ASSOCIATED FACTORS
H Blakstad, EE Mendoza Mireles, LC Heggebø, H Magelssen, ...
Neuro-Oncology 25 (Supplement_2), ii93-ii93, 2023
Mandates: European Commission
Review
Neuro-Oncology Practice
H Blakstad, EEM Mireles, LC Heggebø, H Magelssen, M Sprauten, ...
Mandates: European Commission, Research Council of Norway
Review
Magnetic Resonance Imaging for Quantification of Brain Vascular Perfusion
LB Nilsen, KE Emblem
Brain Tumors, 289-321, 2021
Mandates: European Commission
Available somewhere: 67
Review
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
TT Batchelor, ER Gerstner, KE Emblem, DG Duda, J Kalpathy-Cramer, ...
Proceedings of the national academy of sciences 110 (47), 19059-19064, 2013
Mandates: US National Institutes of Health
Review
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion
AG Sorensen, KE Emblem, P Polaskova, D Jennings, H Kim, ...
Cancer research 72 (2), 402-407, 2012
Mandates: US National Institutes of Health
Review
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
KE Emblem, K Mouridsen, A Bjornerud, CT Farrar, D Jennings, RJH Borra, ...
Nature medicine 19 (9), 1178-1183, 2013
Mandates: US National Institutes of Health, Danish National Research Foundation
Review
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
G Seano, HT Nia, KE Emblem, M Datta, J Ren, S Krishnan, J Kloepper, ...
Nature biomedical engineering 3 (3), 230-245, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, German …
Review
Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma
C Lu-Emerson, DG Duda, KE Emblem, JW Taylor, ER Gerstner, ...
Journal of Clinical Oncology 33 (10), 1197-1213, 2015
Mandates: US National Institutes of Health, Research Council of Norway
Review
Advanced magnetic resonance imaging of the physical processes in human glioblastoma
J Kalpathy-Cramer, ER Gerstner, KE Emblem, OC Andronesi, B Rosen
Cancer research 74 (17), 4622-4637, 2014
Mandates: US National Institutes of Health
Review
T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties
A Bjornerud, AG Sorensen, K Mouridsen, KE Emblem
Journal of Cerebral Blood Flow & Metabolism 31 (10), 2041-2053, 2011
Mandates: US National Institutes of Health
Review
A generic support vector machine model for preoperative glioma survival associations
KE Emblem, MC Pinho, FG Zöllner, P Due-Tonnessen, JK Hald, ...
Radiology 275 (1), 228-234, 2015
Mandates: Research Council of Norway
Review
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
J Kalpathy-Cramer, V Chandra, X Da, Y Ou, KE Emblem, A Muzikansky, ...
Journal of neuro-oncology 131, 603-610, 2017
Mandates: US National Institutes of Health
Review
A fully automated deep learning network for brain tumor segmentation
CGB Yogananda, BR Shah, M Vejdani-Jahromi, SS Nalawade, ...
Tomography 6 (2), 186, 2020
Mandates: US National Institutes of Health, Research Council of Norway
Review
Vessel calibre—a potential MRI biomarker of tumour response in clinical trials
KE Emblem, CT Farrar, ER Gerstner, TT Batchelor, RJH Borra, BR Rosen, ...
Nature reviews Clinical oncology 11 (10), 566-584, 2014
Mandates: US National Institutes of Health, Academy of Finland
Review
Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma
ER Gerstner, KE Emblem, K Chang, B Vakulenko-Lagun, YF Yen, ...
Clinical Cancer Research 26 (1), 206-212, 2020
Mandates: US National Institutes of Health, European Commission, Research Council of …
Review
Towards patient-specific modeling of brain tumor growth and formation of secondary nodes guided by DTI-MRI
S Angeli, KE Emblem, P Due-Tonnessen, T Stylianopoulos
NeuroImage: Clinical 20, 664-673, 2018
Mandates: European Commission, Research Council of Norway
Review
Repeatability of cerebral perfusion using dynamic susceptibility contrast MRI in glioblastoma patients
K Jafari-Khouzani, KE Emblem, J Kalpathy-Cramer, A Bjørnerud, ...
Translational oncology 8 (3), 137-146, 2015
Mandates: US National Institutes of Health, Research Council of Norway
Review
Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
E Grøvik, D Yi, M Iv, E Tong, LB Nilsen, A Latysheva, C Saxhaug, ...
NPJ digital medicine 4 (1), 33, 2021
Mandates: European Commission, Research Council of Norway
Publication and funding information is determined automatically by a computer program